By A Mystery Man Writer
Cancer antigen 27.29 (CA 27.29) is a blood test that monitors metastatic breast cancer. Although valuable, it has limitations in what it can detect.
Table 4 from Comparison of the diagnostic accuracy of CA27.29 and
tumor markers, CA-15-3 is used to monitor the breast cancer
CA 15-3: Reference Range, Interpretation, Collection and Panels
Cancers, Free Full-Text
Frontiers AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study
Cancer Antigen 27.29 Test: Uses, Procedure, Results
Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125
Frontiers Clinical validation of the novel CLIA-CA-62 assay
Frontiers Clinical validation of the novel CLIA-CA-62 assay
What Breast Medical Oncologists Need From Pathologists